Weight loss drugs may enhance brain health in diabetes

A recent study found that semaglutide, the active ingredient in Ozempic and Wegovy, may improve brain health in type 2 diabetes patients. Analyzing over 20,000 health records, researchers noted a lower risk of nicotine dependence and dementia among semaglutide users compared to other diabetes medications. The findings suggest potential cognitive benefits, prompting further investigation into semaglutide's neurological effects, particularly in Alzheimer's treatment.